Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Prospective Registry to Evaluate Use and Outcomes of Burst Biologics Products in Spinal Fusion Surgery

NCT03064802 is registered in ClinicalTrials.gov with Burst Biologics as lead sponsor.

NCT NCT03064802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03064802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Prospective Registry to Evaluate Use and Outcomes of Burst Biologics Products in Spinal Fusion Surgery
Lead sponsor
Burst Biologics
Phase
Observational
Overall status
Unknown status
Start date
March 24, 2017
Completion date
November 30, 2020
Enrollment
450 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, herniated disk, spinal stenosis, spondylitis, spondylolisthesis